IMPORTANT ITEMS TO REMEMBER:
There will be two poster sessions at the annual meeting. Posters ending in an odd number will be on display on Thursday, April 8. Posters ending in an even number will be on display on Friday, April 9. Authors are only required to be present during their assigned display time. Posters will be set-up and displayed in the exhibit hall.
Poster Guidelines
If your poster board number ends in an odd number:
- Set up your poster on Thursday, April 8 between 8:30-11:45 am.
- Please be at your poster on Thursday from 5:45-6:45 pm (you only need to be present during this author-attended session)
- Your poster must be removed between 7:30-8:15 pm on Thursday, April 8. ASPHO cannot be held responsible for any posters remaining on boards after this time.
If your poster board number ends in an even number:
- Set up your poster on Friday, April 9 between 7:00-10:45 am.
- Please be at your poster on Friday from 12:30-1:45 pm (you only need to be present during this author-attended session)
- Your poster must be removed between 4:15-5 pm on Friday, April 9. ASPHO cannot be held responsible for any posters remaining on boards after this time.
Please plan to be available during your assigned author-attended session so that you can discuss your work and answer questions from attendees. The author-attended sessions are relatively informal, with attendees visiting several posters during the allotted time period. You are not expected to prepare a formal presentation, but should be ready to discuss your work with attendees who stop to view your poster.
| Primary Author | Assigned Poster Number |
Abstract Title |
| Filemon Dela Cruz | 100 | Safety, Dose Escalation and Efficacy of Gemtuzumab Ozogamicin in Combination with a Myeloablative Conditioning Regimen and AlloSCT in Children with High-Risk CD33+ AML and Myelodysplastic Syndrome: A Novel Chemoimmunotherapy Conditioning Regimen |
| Craig Mullen |
101 | Leukemia Antibodies in Survivors of Allogeneic Transplant: Potential Role of B Cells in GVL Effect |
| Mark Geyer |
102 | Preliminary Results of Dose Escalation of Clofarabine in Combination with Cytarabine and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Children and Young Adults (CAYA) with Poor-Risk Acute Leukemia |
|
Jessica Brown |
103 | Analysis of the Incidence and Characteristics of Venoocclusive Disease (VOD) of the Liver in Pediatric Hematopoietic Progenitor Cell Transplant (HPCT) Patients with Heparin alone vs. Heparin and Ursodiol Prophylaxis at the Medical College of Wisconsin |
| Christine Phillips |
104 | Computed Tomography Induced Double-stranded DNA breaks as a Potential Marker of Radiation Sensitivity in Fanconi Anemia |
| Parinda Mehta |
105 | Alternate day Micafungin Anti-fungal Prophylaxis in Pediatric Patients undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Pharmacokinetic (PK) study |
| Terrie Flatt |
106 | Characteristics and Outcome of Pediatric Stem Cell Transplant Patients with Invasive Fungal Infection |
| Jamie Dargart |
107 | Adverse Outcomes in Underweight Child and Adolescent Survivors of Cancer and Recipients of Hematopoietic Stem Cell Transplant |
| Meerim Park |
108 |
The Role of Pulmonary Function Test for the Early Detection of Subsequent Late-Onset Non-Infectious Pulmonary Complications in Children |
| Rahul Naithani |
109 | Outcome after Hematopoietic Stem Cell Transplantation in Children with Hemophagocytic Lymphohistiocytosis at The Hospital for Sick Children, Toronto (SickKids) |
| Amulya Nageswara Rao | 110 |
Pretransplant Conditioning with Campath-1H (Alemtuzumab) in Pediatric Matched Unrelated Bone Marrow Transplants - An Institutional Experience |
|
Megan Sikorski |
111 | Patient and Family Views Regarding In-Vitro Fertilization with Therapeutic Intent for Sickle Cell Disease |
| Lawrence Faulkner |
112 |
Safe and Effective Reduced-Cost Bone Marrow Transplantation for Thalassemia: The Preliminary Experience of the Cure2Children Foundation in Pakistan |
| Andrew Dietz |
113 | Disease-specific Hematopoietic Cell Transplantation: Reduced Intensity Conditioning Regimen for Dyskeratosis Congenita |
| Sharon Singh |
114 | Hematopoietic Differentiation Defects in Rps19-Deficient Murine Embryonic Stem Cells and Rescue by Gene Replacement |
| Ellen Fung |
115 | Zinc Supplementation Improves Bone Density in Patients with Thalassemia |
| Rahul Naithani |
116 | Safety and Efficacy of Zoledronic Acid in Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major |
| Adrienne Hammill |
117 | Rapamycin for the Treatment of Complicated Vascular Anomalies |
| Geetha Puthenveetil |
118 | New Approach in treating Pediatric Hemangiomas |
| Melissa DeLario |
119 | Primary Myelofibrosis in Children |
| Kasiani Myers |
120 | Longitudinal Assessment of Clonal Changes in Hematopoeisis in Fanconi Anemia Patients |
| Ellen Fung |
121 | Inadequate Dietary Intake in Patients with Thalassemia |
| Anurah Agrawal |
122 | Rate of Packed Red Blood Cell Transfusion in Pediatric Patients With Severe Chronic Anemia and Normal Cardiopulmonary Status: How Slow Is Truly Necessary? |
| Kasiani Myers |
123 | Immunological Function in Children with Fanconi Anemia |
| Sherif Badaway |
124 | Evaluation of Iron Chelation Therapy in B-thalassemic Patients in Zagazig University Hospital |
| Kris Mahedeo |
125 | Hereditary Folate Malabsorption due to Mutation at the Arginine 376 Residue; Substrate-Specific Changes in function and pH-dependence |
| Jacqueline Halton |
126 | Trends in Physician Resources for Canadian Pediatric Hematology Oncology Programs from 1999 to 2009 |
| Andrzej Rochowski |
127 | Neutrophil function in patients with Inherited Bone Marrow Failure Syndromes |
| Arif Manji |
128 |
The first report of a solid tumor in Shwachman-Diamond syndrome (SDS): a clinical and genetic analysis |
| David Shyr |
129 | Effect of Immune Therapy on PNH Clone Size and Bone Marrow Cellularity |
| Melissa Frei-Jones |
130 | Frequency of Minor Blood Group Antigens Among Hispanic Blood Donors in South Texas |
| Lalit Bansal |
131 | Novel G6PC3 Mutation and Cinical Course in a Child of Dominican Ancestry |
| Jessica Scerbo |
132 |
Radiation-Induced Moyamoya Syndrome in Suprasellar Germ Cell Tumor |
| Mohamad Al-Rahawan | 133 | Anemia and Health-Related Quality of Life in Pediatric Patients Undergoing Treatment for Acute Myeloid Leukemia or Osteosarcoma |
| Paul Gordon |
134 | Endothelin Receptor Antagonist for Pulmonary Hyertension in Pediatric Patient with Sickle Cell Disease |
| Kate Gowans |
135 | VTE Prophylaxis in a Children's Hospital: Practices and Opportunities for Improvement |
| William Dalzell |
136 | Prevalence Rate of Methicillin-resistant Staphylococcus aureus colonization in Hospitalized Pediatric Oncology Patients |
| Cristina Fernandes | 137 | Resolution of Multisystem LCH following Liver Transplantation without Chemotherapy: A Case Report |
| Ernest Fruge |
138 | Defining and Managing Career Challenges for Middle and Senior Stage Pediatric Hematologist/Oncologists |
| Lynn Malec |
139 | Development of Deep Vein Thrombosis and Pulmonary Emboli in the Setting of Osteomyelitis |
| Shilpa Jain |
140 | Characterization of miRNA Expression Profile in Platelets in Sickle Cell Disease |
| Trinh Nguyen |
141 | A Novel Tolerogen Prevents Inhibitor Formation in a Mouse Model of Hemophilia A |
| Stacy Croteau | 142 | The Spectrum of Kaposiform Hemangioendothelioma: A Review of 107 Cases Elucidates Atypical Presentations and Risk Factors for Kasabach-Merritt Phenomenon |
| Guy Young | 143 | Fondaparinux in Children: A Prospective, Dose-finding, Pharmacokinetic and Safety Study |
| Robert Sidonio Jr. |
144 | Cost-utility Analysis of Von Willebrand Disease Screening in Adolescents with Menorrhagia |
| Lakshmanan Krishnamurti |
145 | Current In-Hospital Mortality, Age-Varying Co-Morbidities, and Health-Care Utilization for Hemophilia in Pediatric and Adult Patients in United States: First Reported Nationwide Estimates |
| Henri Justino |
146 | Extensive Superior Vena Cava Thrombosis in Infants and Children: Results of Catheter Intervention |
| Lynn Malec |
147 | A Cost-Utility Analysis of Cranial Imaging in Neonates with Hemophilia |
| Catherine Segbefia |
148 | Severity and Pattern of Epistaxis in Children with von Willebrand Disease (VWD) or a Platelet Function Disorder (PFD) |
| Neha Bhasin |
149 | Diagnostic Outcome of Preoperative Coagulation Testing on 791 Children |
| Viola Van Eimeren |
150 | Insights into the Uptake and Release of Complement Factor H by Platelets |
| Anjali Sharathkumar | 151 | Post-thrombotic Syndrome (PTS) in Children with Venous Thromboembolism (VTE): A Longitudinal Follow up Study |
| Rebecca Cook |
152 | Single Center Experience with Implanted Venous Access Devices in Children with Inherited Bleeding Disorders |
| Victor Blanchette |
153 | Effect of Romiplostim on Parental Burden and Health-Related Quality of Life (HRQOL) in Children With Chronic Immune Thrombocytopenia (ITP) |
| Grace Onimoe |
154 | A Single Institution Experience with CHD-related AvWS: Does it impact bleeding risk? |
| Mindy Grunzke |
155 | Young Adult Onset of Recurrent Thromboembolism in a Patient with Congenital Afibrinogenemia |
| Claudio Sandoval |
156 | Racial Disparities in Pediatric Immune Thrombocytopenic Purpura |
| Erin Guest |
157 | Successful Liver Transplantation to Correct Severe Congenital Factor V Deficiency in a Child with Multiple Intracranial Hemorrhages |
| Paul Moorehead |
158 | Risk Factors for Clinically Significant Bleeding in the Pediatric Intensive Care Unit |
| Hamayun Imran |
159 | Risk Factors and Outcomes in Childhood Arterial Ischemic Stroke: A Single Institution Experience |
| Ralph Gruppo |
160 | A Comparison of Dosing of Recombinant Factor VIIa (rFVIIa) in Pediatric versus Adult Patients with Congenital Hemophilia with Inhibitors (CHwI): Prescription and Actual Data from the Dosing Observational Study in Hemophilia (DOSE) |
| Jordan Wright | 161 | Venous Thromboembolism in Pediatric Patients: Epidemiologic Data from a Pediatric Tertiary Care Center |
| Liliana Lojo | 162 | Integrating Combinatorial CYP2C9 and VKORC1 Genotypes into Clinical Warfarin Management in Puerto Rican Children with Thrombosis: An Illustrative Cases Study |
| Cori Morrison |
163 | Acquired Factor IX Inhibitor and Subsequent Resolution with Immunotherapy in a Child with Acquired Immunodeficiency Syndrome |
| Pablo Rendo |
164 | Safety of BeneFIX® (Nonacog Alfa, Recombinant Human Factor IX) for Usual Use in Pediatric Patients: Results from a Prospective Registry of European Hemophilia B Patients |
| Patrick Zweidler McKay | 165 | A Novel Cell-specific Mechanism of Notch Signaling in Acute Lymphoblastic Leukemias - PARP1:HES1 Ratios |
| Mignon Loh |
166 | Germline Mutations in CBL Cause a Predisposition to Juvenile Myelomonocytic Leukemia |
| Alejandro Gutierrez |
167 | Absence of Biallelic TCRγ Deletions (ABGD) Predicts Induction Failure in Pediatric T-ALL |
| Theodore Johnson |
168 | Mechanism of Etoposide Activity in Treating Murine Hemophagocytic Lymphohistiocytosis |
| Theodore Johnson |
169 | T Cell-Directed Biological Therapy for Murine Hemophagocytic Lymphohistiocytosis |
| Michael Rytting |
170 | Augmented Berlin-Frankfurt-Muenster Therapy in Adolescents and Young Adults with Acute Lymphoblastic Leukemia |
| V. Koneti Rao | 171 | Development of Lymphomas in Families with Autoimmune Lymphoproliferative Syndrome (ALPS) |
| Colleen Morrison |
172 | Expression of the Embryonic Morphogen, Nodal, in Pediatric Acute Lymphoblastic Leukemia |
| Kasiani Myers |
173 | Pathway Based Evaluation of Cytarabine Pharmacogenetics in Children with Acute Myeloid Leukemia |
| Joy Fullbright |
174 | Role of Reactive Oxygen Species in Amrubicin's Decreased Cardiotoxicity and its Leukemia Cell Cytotoxicity |
| Aru Narendran |
175 | SJG-136 (NSC 694501), A unique DNA Minor Groove Interstrand Cross-Linking Agent Shows Significant Activity and Drug Combinability Against Aggressive Types of Pediatric Leukemia |
| Kenneth McClain |
176 | Serum Ferritin as an Outcome Predictor in Patients with Hemophagocytic Lymphohistiocytosis |
| Robin Perry |
177 | A Physiologic Chemotherapy Model for Acute Myeloid Leukemia in Xenotransplanted Mice |
| Nina Rolf |
178 | Toll like receptor 2 (TLR2) agonists as a promising treatment option for acute lymphatic leukemia (ALL) in children: preliminary results for TLR2/1 and TLR2/6 agonists in pre B-ALL |
| Anurag Agrawal |
179 | Is Routine Computed Tomographic Scanning Justified in the Early Days of Persistent Febrile Neutropenia in Children With Malignancies? |
| Etan ORgel |
180 | Pediatric Neutropenic Cancer Patients have Significantly Less Catheter-Related Morbidity with Total Implantable Devices |
| Nyla Heerema |
181 | Amplification of AML1 Does Not Impact Early Event-Free Survival (EFS) or Overall Survival (OS) of Children with Acute Lymphoblastic Leukemia (ALL) Treated with Risk-Directed Chemotherapy: A Report from the Childrenâ€Ms Oncology Group (COG) |
| Jeffrey Andolina |
182 | The class IV G-CSF Receptor Drives Dose-dependent Altered Growth and Differentiation, which is Associated with Enhanced Src Activation |
| Patrick Zweidler-McKay | 183 | Insights into Immune Suppression during ALL Induction Therapy: Can CD4+ T Cells Save the Day? |
| Abdul Siddiqui | 184 | Enhanced Elimination of 6-mercaptopurine or Methotrexate-treated ALL Cells by Natural Killer Lymphocytes in Vitro: a Potential Mechanism of Action of Maintenance Chemotherapy |
| Dan Wechsler |
185 | CALM Deficiency Alters Expression and Endocytosis of Growth Factor Receptors |
| Judith Johnson |
186 | STXBP2 (MUNC18-2) Mutations in North American Patients with Familial Hemophagocytic Lymphohistiocytosis |
| Aaron Reitman |
187 | Serial Procalcitonin Levels for Bacteremia in Pediatric Patients with Fever and Severe Neutropenia |
| Keith August |
188 | Hypersensitivity Reactions to PEG-Asparaginase in Children Following Intravenous Administration |
| Mark Fluchel |
189 | External Venous Catheters Have a Higher Rate of Early Removal than Subcutaneous Ports in Pediatric Cancer Patients |
| Shadi Farzingohar |
190 | Does fMRI add to a Multivariate Assessment of Cognitive Outcome in Survivors of Childhood Acute Lymphoblastic Leukemia |
| Susan Rheingold |
191 | Improvement of Outpatient Onocology Clinic Efficiency Utilizing Standardized Clinic Tracking Data |
| Sumit Gupta |
192 | Incidence and Predictors of Treatment Related Mortality in Acute Lymphoblastic Leukemia in Three Central American Countries |
| Nick Vitanza |
193 | The Progression of Bone Mineral Density Abnormalities Post-Chemotherapy in Children with ALL |
| Mark Fluchel | 194 | Subcutaneous Ports versus External Venous Catheters from the Perspective of Pediatric Oncology Patients and Their Families |
| Erick Castellanos |
195 | A Response-Based Abvd Regimen with or Without Radiotherapy for Pediatric Low and Intermediate Risk Hodgkin Lymphoma in Central America and Dominican Republic a Report from Ahopca |
| Adam Esbenshade |
196 | Dapsone Induced Methemoglobinemia: A Dose Related Occurrence? |
| Adam Levy |
197 | Mentoring in Pediatric Oncology Clinical Trials: A Report from the Children's Oncology Group (COG) Young Investigators Committee |
| Riten Kumar |
198 | Rituximab based Chemotherapy for Pediatric Follicular Lymphoma: A Single Institution Experience |
| Holly Knoderer |
199 | Hyperphosphatemia in Children Receiving Liposomal Amphotericin B |
| Peter Cole |
200 | Methotrexate Induces Measurable Deficits in Verbal Memory Within Days of Exposure |
| Lakshmanan Krishnamurti |
201 | Hospital Utilization and Mortality of Febrile Neutropenia in Childhood Acute Leukemia in the United States |
| Ramasubramanian Kalpatthi | 202 | Potentiation of Vincristine Toxicity with Concomitant Fluconazole Prophylaxis in Children with Acute Lymphoblastic Leukemia |
| Rachel Brennan |
203 | Characteristics and Implications of Spinal Epidural Lipomatosis in Children with Hematologic Malignancies |
| Osman Khan | 204 | Induction of Autophagy by Sphingosine Kinase Inhibitor |
| Carrye Cost |
205 |
2009 Pandemic H1N1 Influenza A in Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients: A Review of a Single Center Experience |
| Tamra Slone | 206 | Evaluation of Late Cardiotoxicity in Children Who Received Low Dose Anthracyclines for Treatment of Pediatric Cancer |
| Robert Irwin |
207 | Improving Leukemia Care Documentation with the Electronic Medical Record |
| Matthew Kelly |
208 | Risk Factors for Central Line-Associated Bloodstream Infection in Pediatric Oncology Patients |
| Matthew Murray |
209 | Malarial Episodes in Paediatric Oncology Patients in Senegal: a Retrospective, Single-centre Study |
| Adriana Linares |
210 | Peripheral T Cell Lymphoma in Children: A single Center Experience in Colombia |
| Hanumantha Pokala |
211 |
The Association of Hospital Construction with the Development of Environmental Health Care-Associated Mold Infections (EHCAMI) in Children with Acute Leukemia |
| Linda Butros |
212 | Growth Hormone Deficiency Affects a Significant Population of T-ALL Survivors |
| MathewZachariah | 213 | Effective use of Single Dose of Darbepoetin Alpha in Reducing Blood Transfusion during Induction Chemotherapy in Leukemic Childre |
| Riten Kumar |
214 | Histiocytic Sarcoma during Maintenance Chemotherapy for Precursor B Acute Lymphoblastic Leukemia: Case Report with Evidence for a Common Clonal Origin |
| Emily Mueller |
215 | Addressing the Barriers of Neurocognitive Screening in Long-term Survivors of Pediatric Cancer: A brief neurocognitive screening method |
| Nayera Hamdy |
216 | Prevalence of FLT3 Internal Tandem Duplication in Pediatric Patients with Acute Myeloid Leukemia at Children Cancer Hospital EGYPT (CCHE) |
| Kelly McCrann |
217 | Improving Pediatric Survivorship Care: A Needs-Based Assessment of General Practitioners Regarding Late Effects of Childhood Cancer Treatment in Adult Survivors of Pediatric Cancer |
| Evangeline Brown | 218 | Perioral and Facial Paresthesias associated with intravenous Pentamidine use for Pneumocystis Prophylaxis |
| Stefanos Intzes | 219 | Aberrant mast cells and AML with t(8;21): Case Report in a 3 Year Old Child |
| Angela Punnet |
220 | Information Needs of Families of Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) |
| Riten Kumar | 221 | Acute Bilineal Leukemia associated with 9q Deletion and HOX11L2/BCL11B t(5;14)(q35;q32) Fusion: Successful Management with ALL Based Chemotherapy and Unrelated Cord Blood Transplant |
| Ralph Salloum | 222 | Ethanol Lock Therapy for Catheter-Related Blood Stream Infections in Pediatric Patients with a Hematologic or Oncologic diagnosis |
| Jason Canner |
223 | Surveillance Following Head, Neck and Chest Radiotherapy: Thyroid Ultrasounds Monitoring for Secondary Thyroid Malignancy |
| Kris Mahadeo | 224 | Systemic Mastocytosis in a child with t(8;21) Acute Myeloid Leukemia |
| Paul Gibson |
225 | CD56 Expression as a Prognostic Indicator in Pediatric AML: A Single Centre Review |
| Hanumantha Pokala | 226 | The Management of Post-Transplant Lymphoproliferative Disorder Resembling Primary CNS Lymphoma in a Pediatric Renal Transplant Patient |
| Shadi Farzingohar |
227 | Feasibility and Parent Satisfaction of a Physical Therapy Intervention Program for Children with Acute Lymphoblastic Leukemia in the First Six Months of Medical Treatment |
| Anu Narla | 228 | Maximizing the Use of TMP-SMZ for PCP prophylaxis in Pediatric Oncology Patients |
| DerekHanson | 229 | Ehrlichia-induced Hemophagocytic Lymphohistiocytosis in Two Children |
| Chatchawin Assanasen |
230 | Epidemiologic Mapping of Florida Childhood Cancer Clusters: An Update |
| Amy Lee |
231 | Capnocytophaga Species Associated Mortality in a Child with AML |
| Amy Sobota |
233 | Thirty Day Readmission Rates Following Hospitalization for Sickle Cell Anemia Crisis at Freestanding Childrenâ€Ms Hospitals |
| Connie Piccone |
234 | Redefining Chronic Hemolysis in Pediatric Sickle Cell Disease: Focus on Symptomatic Cholelithiasis |
| Alex George |
235 | Sickle Red Blood Cells Have Increased Phosphorylation of Adducin and Increased Reactive Oxygen Species Production Mediated by Signaling Pathways Involving PKC and Rac GTPases |
| Charles Quinn | 236 |
Cerebral Tissue Hemoglobin Desaturation in Children with Sickle Cell Disease |
| Suvimol Sangkatumvong |
237 | Decrease in Microvascular Blood Flow in Sickle Cell Anemia Triggered by Autonomic Responses to Sighing |
| Sani Mathew | 238 | Medical and Quality of Life Indications for Splenectomy in Children with Hereditary Spherocytosis |
| Timothy McCavit | 239 | National Trends in Hospitalization for Stroke in Children with Sickle Cell Disease Since Publication of the STOP Trial |
| Rafat Ahmed |
240 | Serum Macrophage Migration Inhibitory Factor (MIF) Level Predicts Acute Chest Syndrome In Patients With Sickle Cell Disease |
| Melanie Bonner | 241 | Neurocognitive Functioning and Quality of Life among Children with Sickle Cell Anemia and Stroke |
| Amanda Brandow |
242 | Evaluation of Children with Sickle Cell Disease Treated for Chronic or Recurrent Pain using a Multidimensional Pain Management Model |
| Adrianna Vlachos |
243 | Neoplasia in Diamond Blackfan Anemia (DBA) as reported to the Diamond Blackfan Anemia Registry (DBAR) |
| Naomi Luban |
244 | Erythrocyte Allo- and Auto-Antibody Formation in Sickle Cell Anemia during Stroke Prophylaxis |
| Stephen Nelson |
245 | Iron-induced Hemolysis in Preterm Infants |
| Courtney Thornburg |
246 | Association between hydroxyurea and health-related quality of life in children with sickle cell disease |
| Anthony Audino |
247 | Prognostic Value of Pro-BNP and VEGF in Children with Sickle Cell Disease |
| Lakshmanan Krishnamurti | 248 | Nationwide Utilization of Packed Red Blood Cell Transfusions for the Treatment of Uncomplicated Iron Deficiency Anemia |
| Amanda Epping |
249 | Transitional Care: Educational and Employment Outcomes of Adults with Sickle Cell Disease |
| Fredric Hoffer |
250 | Liver Biopsy in Chronically Transfused Children with Sickle Cell Anemia and Stroke |
| David Goldberg |
251 | A Prolonged QTc is Not Associated with Increased Mortality in Sickle Cell Disease |
| Amy Sobota |
252 | Parent-Reported Quality of Life in a Cohort of Patients with Thalassemia |
| Suzanne Reed |
253 | Prescription Contraception Use in Adolescents and Young Adults with Sickle Cell Disease: Analysis of Michigan Medicaid Claims |
| Ofelia Alvarez |
254 | Increased Prevalence of False Positive Newborn Hemoglobinopathy Screening in Premature Infants |
| Beth McCarville | 255 | Abdominal Ultrasonography Findings in Chronically Transfused Children with Sickle Cell Anemia |
| Lakshmanan Krishnamurti |
256 | National Estimates of Healthcare Utilization for Sickle Cell Vasocclusive Crises: Shorter Hosptal Stay and Lower Costs for Pediatric Patients |
| Lakshmanan Krishnamurti | 257 | Factors predicting Hospital Admission following a visit to the Emergency Room for Sickle Cell Crisis |
| Beng Fuh |
258 | Prevalence Rate of Methicillin-resistant Staphylococcus aureus colonization in Hospitalized Pediatric Sickle Cell Disease Patients |
| Stephen Nelson |
259 | Perceptions of how race affects health care delivery in a Sickle Cell program |
| Stephen Nelson |
260 | Wind speed and not temperature is associated with painful events in children with sickle cell disease in the Twin Cities |
| James Cooper | 261 | Decreased Frequency of Vaso-Occlusive Crises Associated with Intravenous Immune Globulin in a Patient with Sickle Cell Disease |
| Banu Aygun |
262 | Concomitant Use of Hydroxyurea and Deferasirox in Children with Sickle Cell Anemia |
| Shalu Narang |
263 | Bacteremia in Children with Sickle Hemoglobinopathies |
| Yasser Wali |
264 | Double Heterozygous HbS-S Oman: A new Syndrome of Sickle cell disease presenting as thalassemia major |
| Deepti Raybagkar | 265 | Direct Antiglobulin Test (DAT) negative mixed IgA and IgG mediated (anti-e specific) autoimmune hemolytic anemia (AIHA) in an infant |
| Kishor Bhende |
266 | Novel unstable hemoglobin variant: Heterozygous frameshift mutation of β globin chain on codon 121 at position 416 |
| Elliot Vichinsky |
267 | Successful Hematopoietic Cell Transplantation for Alpha Thalassemia Major |
| Angel Castro |
268 | Pulmonar Hypertension in Children with Sickle Cell Disease living at High Altitude: A Single Center Experience in Bogota-Colombia |
| Jason Shohet |
269 | High Throughput Sequencing and Chromatin Immunoprecipitation (Chip-Seq) Identifies MYCN-Regulated Micrornas as Tumor Suppressors and Oncogenes in Neuroblastoma |
| Tom Badgett |
270 | Next Generation Sequencing of the Neuroblastoma Transcriptome Identifies Multiple Protein Disrupting Mutations |
| Jin Chang |
271 | Identification and Characterization of Cancer Initiating Cells in Osteosarcoma |
| Anita Villani |
272 | Early Detection Strategies Reduce Cancer Mortality in Germline TP53 Mutation Carriers in Li-Fraumeni Syndrome |
| Brian Belyea | 273 | The Notch Signaling Pathway as a Therapeutic Target in Rhabdomyosarcoma |
| Nino Rainusso | 274 | Targeting Cancer Stem Cells in Osteosarcoma |
| John Craddock |
275 | CCR2b-Transduced Cytotoxic T Lymphocytes Show Enhanced Homing In Vivo Toward CCL2-Secreting Neuroblastoma: Implications for Enhanced Adoptive Immunotherapy |
| Takrima Haque | 276 | Derailed Receptor Tyrosine Kinase Endocytosis in Glioblastoma: Sorting Nexin 3 Disrupts EGFR and MET Trafficking Promoting Cell Proliferation and Tumorigenicity |
| Nisha Kakodkar |
277 | Anti-angiogenic and Anti-neoplastic Effects of the Multikinase Inhibitor Sorafenib in Neuroblastoma |
| Navin Pinto |
278 | Development of an Automated Quantitative Method for Scoring Metaiodobenzylguanidine (mIBG) Scans in Patients with Neuroblastoma |
| Coleen Druzgal |
279 | Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Parrafin-Embedded (FFPE) Samples of Ewing's Sacoma |
| Grace Onimoe |
280 | Novel STAT 3 Inhibitors FLLL32 and LLL12 Inhibit STAT3 Phosphorylation and Induce Apoptosis in Human Osteosarcoma Cells |
| Bhuvana Setty |
281 | Hypoxia induced human osteosarcoma cell proliferation requires arginase II induction |
| Suman Malempati |
282 | Rhabdomyosarcoma in Infants Less than One Year of Age: Results from the Children's Oncology Group |
| Carola Arndt |
283 | Inhaled GM-CSF for First Pulmonary Recurrence of Osteosarcoma. A Report from the Children's Oncology Group |
| Issai Vanan |
284 | Role of MRK kinase in radiation- induced invasion in high-grade gliomas |
| Rima Jubran | 285 | A Comparison of Two Treatment Regimens for Group B Intraocular Retinoblastoma |
| Keith August |
286 | The Use of Zoledronic Acid in Children with Solid Tumors |
| Karine Jacob | 287 | Are the Juvenile Pilocytic Astrocytomas the Naevi of the Brain? |
| Xiaxin Li | 288 | Clinical Features of Pleomorphic Xanthoastrocytoma |
| Candy Chen |
289 | Differential Activation of the RAS Pathway in Rhabdomyosarcoma Subtypes |
| Adam Fleming | 290 | Redefining the Incidence and Outcomes of CNS Atypical Teratoid Rhabdoid Tumours at BC Children's Hospital |
| Kiyomi Goto |
291 | MycN is Associated with Loss of miR-206 in a Genetically Defined Model of Alveolar Rhabdomyosarcoma |
| Christopher Rokes |
292 | Retinoic Acid Promotes Proteasomal Degradation of REST and Neuronal Differentiation in Neuroblastoma Cells |
| David Eisenstat |
293 | Role of DLX2 Homeobox Genes in Retinoblastoma Differentiation |
| Jeffrey Knipstein |
294 | Histone Deacetylase Inhibition as Therapy for Atypical Teratoid/Rhabdoid Tumor: Preliminary In Vitro Analysis |
| Xiao-Yang Liu |
295 | Sub-cellular Localization of Y-Box Protein 1 Regulates Proliferation, Invasion, and Increased Mesenchymal Phenotype in Astrocytomas |
| Dipti Dighe |
296 |
Differentiation therapy in rhabdomyosarcoma: Developing a high throughput screen for skeletal muscle differentiation |
| Adrienne Hammill | 297 | Neuroblastoma Tumorspheres Are Enriched for Less Differentiated Cells Consistent with the Cancer Stem Cell Hypothesis |
| Dennis Hughes | 298 | Driven to Death: Farnesyl Transferase Inhibition Causes a Counterintuitive Increase in Ras Activity, Including ERK and P38 Pathway Activation, While Causing Cell Death for Sensitive Osteosarcoma Lines |
| Katrin Scheinemann |
299 |
Salvage repeated chemotherapy for pediatric progressive low-grade gliomas: a population based study |
| S. Rod Rassekh |
300 | Ototoxicity as a Predictor of Outcome in Patients with Osteosarcoma Treated with Cisplatin |
| Madhu Gowda |
301 | The Pattern of the Immune Response Differs in Low-risk vs High-risk Neuroblastoma |
| Jacob Wessler |
302 | Lagtime to Oncologic Diagnoses: A Comparison Between Military and Non-Military Healthcare Systems |
|
Karen Fernandez |
303 | Carcinoid Tumors of the Appendix in Children: 65 Year Experience at a Single Pediatric Institution |
| Donna Johnston | 304 | Timing of Palliative Care Consultation for Pediatric Oncology Patients |
| Kris Ann Schultz |
305 |
Ovarian Tumors in Association with Pleuropulmonary Blastoma: A New Manifestation of the PPB Tumor Syndrome |
| Riten Kumar |
306 | Malignant Melanoma in Pediatric Patients: A Single Institution Experience |
| Allison Yancey |
307 | Gender Is a Predictor of Cisplatin Ototoxicity |
| Amy-Lee Bredlau | 308 | Incidental Brain Lesions in Children: To Treat or Not To Treat? |
| Mira Liebman | 309 |
Pleuropulmonary Blastoma: The Hospital for Sick Children Experience |
| Keri Streby |
310 | Rhabdomyosarcoma in Adolescents and Young Adults at Nationwide Children's Hospital: A 25 year review |
| Zhihong Wang | 311 | MKP-1 Expression and Cisplatin Resistance in Neuroblastoma |
| David Eisenstat | 312 |
Linking DLX Transcription Factors to the WNT/ß-catenin Signaling Pathway: Implications for Intestinal Development and Colorectal Carcinoma |
| Eduard Panosyan |
313 | High Dose Chemotherapy (HDCT) with Autologus Hematopoietic Stem Cell Rescue (AHSCR) for Pediatric Brain Tumor Patients |
| Maurizio Ghisoli |
314 | Pegfilgrastim in Children, Adolescents and Young Adults (C + AYA) With Sarcoma Receiving Interval Compression (IC) Chemotherapy: Vincristine, Adriamycin, Cytoxan (VAdC) alternating with Ifosphamide, Etoposide (IE) every 2 weeks |
| Heather Magnan |
315 | 18FDG-PET for Response Assessment in Desmoplastic Small Round Cell Tumor |
| Puja Gupta |
316 | Sunitinib Treatment of Malignant Pheochromocytoma in a Pediatric Patient |
| Kishor Bhende | 317 | Central Nervous System Rhabdoid Tumors: 10 years experience |
| Pooja Hingorani |
318 | Novel Drug Combination using Gemcitabine, Docetaxel and Bevacizumab in Relapsed and Refractory Pediatric Sarcomas |
| Jennifer Mullinax | 319 | Case of Rhabdomyosarcoma Arising within a Sacrococcygeal Teratoma |
| Catherine Lam |
320 | Quality, Readability, and Social Reach of Websites on Osteosarcoma in Adolescents |
| Doug Hutcheon |
321 | A Pilot Study to Investigate the Association Between DNR Status and Hospital Cost Savings in Pediatric Oncology Patients |
| Jennifer Willert |
322 | The Role of Integrins and Caspase 8 in the Progression of Neuroblastoma |
| Derek Hanson |
323 | Infantile Choriocarcinoma in a Neonate with Massive Liver Involvement Cured with Chemotherapy and Liver Transplant |
| Leslie Doros |
324 | Adolescent with Metastatic Colorectal Signet-Ring Cell Carcinoma with Progression when Transitioned from First-line to Maintenance Therapy |
| Rolla Abu-Arja |
325 | Synchronous primary neuroblastoma in monozygotic twins with distinct presentation, pathology, and outcome |
| Antonello Podda | 326 | Multivisceral transplantation in a patient with unresectable, recurrent hepatoblastoma |
| Satheesh Chonat |
327 | Wernicke's-like Encephalopathy and Generalized Encephalopathy following Treatment in Medulloblastoma |
| Katrin Scheinemann |
328 | Gliomatosis Cerebri in Children - A Multifaceted Disease |
| Van Huynh |
329 | Risk Factors for Wilms Tumor |
| Amy Lee |
330 | Ifosfamide Induced Neuropsychiatric Toxicity in Pediatrics |
| Esther Blanco Alemany |
331 | Secretory Carcinoma of the Breast: A Pediatric Oncology Perspective |
| Melissa Markel |
332 | Nephrotoxicity Common with Osteosarcoma Chemotherapy |